Biochemical and immunological characterization of truncated fragments of the receptor-binding domains of C. difficile Toxin A

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Huang, Jui Hsin ^a,b   Shen, Zhe Qing ^a   Lien, Shu Pei ^a   Hsiao, Kuang Nan ^a   Leng, Chih Hsiang ^a   Chen, Chi Chang ^a   Siu, Leung Kei ^a   Chong, Pele Choi Sing ^a,b,c   Vedantam, Gayatri ^d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL TOXIN; BACTERIAL TOXIN A; HEMAGGLUTININ; LECTIN; TCDA TOXIN; TCDB TOXIN; UNCLASSIFIED DRUG; BACTERIAL VACCINE; ENTEROTOXIN; PEPTIDE FRAGMENT; PROTEIN BINDING; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; ESCHERICHIA COLI; IMMUNE RESPONSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PROTEIN DOMAIN; RECEPTOR BINDING; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CACO-2 CELL LINE; CELL CULTURE; CHEMISTRY; CHLOROCEBUS AETHIOPS; FEMALE; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; VERO CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL TOXINS; BACTERIAL VACCINES; CACO-2 CELLS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CLOSTRIDIUM DIFFICILE; ENTEROTOXINS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; VERO CELLS;

EID: 84942869305     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135045     Document Type: Article

References (55)

1. Knoop FC, Owens M, Crocker IC (1993) Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev 6: 251-265. PMID: 8358706
2. Lyerly DM, Krivan HC, Wilkins TD (1988) Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1: 1-18. PMID: 3144429
3. Kelly CP, LaMont JT (2008) Clostridium difficile - more difficult than ever. N Engl J Med 359: 1932-1940. doi: 10.1056/NEJMra0707500 PMID: 18971494
4. McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV, Sambol SP, et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353: 2433-2441. PMID: 16322603
5. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, et al. (2013) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45: 109-113 doi: 10.1038/ng.2478 PMID: 23222960
6. Sun X, Savidge T, Feng H (2010) The enterotoxicity of Clostridium difficile toxins. Toxins 2: 1848-1880. doi: 10.3390/toxins2071848 PMID: 22069662
7. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 46: 7711-713.
8. Davies AH, Roberts AK, Shone CC, Acharya KR (2011) Super toxins from a super bug: structure and function of Clostridium difficile toxins. Biochem J 436: 517-526. doi: 10.1042/BJ20110106 PMID: 21615333
9. Pruitt RN, Chambers MG, Ng KK, Ohi MD, Lacy DB (2010) Strcutural organization of the functional domains of C. difficile toxins A and B. Proc Natl Acad Sci USA 107: 13467-72. doi: 10.1073/pnas.1002199107 PMID: 20624955
10. Albesa-Jove D, Bertrand T, Carpenter EP, Swain GV, Lim J, Zhang J, et al. (2010) Four distinct structural domains in C. difficile toxin B visualized using SAXA. J Mol Biol 396: 1260-70. doi: 10.1016/j.jmb.2010.01.012 PMID: 20070948
11. Humphreys DP, Wilcox MH (2014) Antibodies for treatment of Clostridium difficile infection. Clin Vaccine Immunol 21: 913-923. doi: 10.1128/CVI.00116-14 PMID: 24789799
12. Wult M, Noren T, Ljungh A, Akerlund T (2012) IgG antibody response to toxins A and B in patients with Clostridium difficile infection. Clin Vaccine Immunol 19: 1552-1554. doi: 10.1128/CVI.00210-12 PMID: 22787196
13. Aronsson B, Granstrom M, Molby R, Nord CE (1985) Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection 3: 97-101.
14. Kyne L, Warny M, Qamar A, Kelly CP (2001) Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357: 189-193. PMID: 11213096
15. Monaghan T, Robins A, Knox A, Sewell HF, Mahida YR (2013) Circulating antibody and memory B-cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis. PLoSOne 8: e74452. doi: 10.1371/journal.pone.0074452 PMID: 24058568
16. Fernie DS, Thomson RO, Batty I, Walker PD (1983) Active and passive immunization to protect against antibiotic associated caecitis in hamsters. Dev Biol Stand 53: 325-332. PMID: 6873474
17. Giannasca PJ, Zhang Z-x, Lei W-d, Boden JA, Giel MA, Monath TP, et al. (1999) Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun 67: 527-538. PMID: 9916055
18. Taylor CP, Tummala S, Molrine D, Davidson L, Farrell RJ, Lembo A, et al. (2008) Open-label, doseescalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine 26: 3404-3409. doi: 10.1016/j.vaccine.2008.04.042 PMID: 18502001
19. Lowy IMD, Molrine D, Leav BA, Blair BM, Baxter R, Gerding DN, et al. (2010) Treatment with monoclonal antibodies against Clostridium difficile toxin. N Engl J Med 362: 197-205. doi: 10.1056/NEJMoa0907635 PMID: 20089970
20. Torres JF, Lyerly DM, Hill JE, Monath TP (1995) Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun 63: 4619-4627. PMID: 7591115
21. Kink JA, Williams JA (1998) Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection. Infect Immun 66: 2018-2025. PMID: 9573084
22. Sauerborn M, Leukel P, von Eichel-Streiber C (1997) The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiol Lett 155: 45-54. PMID: 9345763
23. Seregin SS, Aldhamen YA, Rastall DP, Godbehere S, Amalfitano A (2012) Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice. Vaccine 30: 1492-1501. doi: 10.1016/j.vaccine.2011.12.064 PMID: 22200503
24. Tian JH, Fuhrmann SR, Kluepfel-Stahl S, Carman RJ, Ellingsworth L, Flyer DC (2012). A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models. Vaccine 30: 4249-4258. doi: 10.1016/j.vaccine.2012.04.045 PMID: 22537987
25. Ryan ET, Butterton JR, Smith RN, Carroll PA, Crean TI, Calderwood SB (1997) Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun 65: 2941-2949. PMID: 9199470
26. Ward SJ, Douce G, Figueiredo D, Dougan G, Wren BW (1999) Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun 67: 2145-2152. PMID: 10225867
27. Gardiner DF, Rosenberg T, Zaharatos J, Franco D, Ho DD (2009) A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine 27: 3598-3604. doi: 10.1016/j.vaccine.2009.03.058 PMID: 19464540
28. Permpoonpattana P, Hong HA, Phetcharaburanin J, Huang JM, Cook J, Fairweather NF, et al. (2011) Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B. Infect Immun 79: 2295-2302. doi: 10.1128/IAI.00130-11 PMID: 21482682
29. Leuzzi R, Spencer J, Buckley A, Brettoni C, Martinelli M, Tulli L, et al. (2013) Protective efficacy induced by recombinant Clostridium difficile toxin fragments. Infect Immun 81: 2851-2860. doi: 10.1128/IAI.01341-12 PMID: 23716610
30. Dove CH, Wang SZ, Price SB, Phelps CJ, Lyerly DM, Wilkins TD, et al. (1990) Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 58: 480-488. PMID: 2105276
31. Ho JG, Greco A, Rupnik M, Ng KK (2005) Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A. Proc Natl Acad Sci USA 102: 18373-18378. PMID: 16344467
32. Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M, Ng KK (2006) Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 13: 460-461. PMID: 16622409
33. Pruitt RN, Lacy DB (2012) Toward a structural understanding of Clostridium difficile toxins A and B. Front Cell Infect Microbiol 2: 28. doi: 10.3389/fcimb.2012.00028 PMID: 22919620
34. Krivan HC, Clark GF, Smith DF, Wilkins TD (1986) Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta1-4GlcNAc. Infect Immun 53: 573-581. PMID: 3744552
35. Dingle T, Wee S, Mulvey GL, Greco A, Kitova EN, Sun J, et al. (2008). Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and Tcd B, expressed by Clostridium difficile. Glycobiology 18: 698-706. doi: 10.1093/glycob/cwn048 PMID: 18509107
36. Huang JH, Wu CW, Lien SP, Hsiao KN, Leng CH, Lin YH, et al. (2015) Biochemical and immunological characterizations of the receptor binding domain of C. difficile toxin B. J Vaccines Vaccin 6: 276-284.
37. Wren BW, Russell RR, Tabaqchali S (1991) Antigenic cross-reactivity and functional inhibition by antibodies to Clostridium difficile toxin A, Streptococcus mutans glucan-binding protein, and a synthetic peptide. Infect Immun 59: 3151-3155. PMID: 1715320
38. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77-92. PMID: 10037236
39. Burger S, Tatge H, Hofmann F, Genth H, Just I, Gerhard R (2003) Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. Biochem Bioph Res Co 307: 584-588.
40. Papatheodorou P, Zamboglou C, Genisyuerek S, Guttenberg G, Aktories K (2010) Clostridial glucosylating toxins enter cells viaclathrin-mediated endocytosis. PLOS ONE 5: e10673. doi: 10.1371/journal.pone.0010673 PMID: 20498856
41. Olling A, Goy S, Hoffmann F, Tatge H, Just I, Gerhard R (2011) The repetitive oligopeptide sequences modulate cytopathic Potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PLoS ONE 6: e17623. doi: 10.1371/journal.pone.0017623 PMID: 21445253
42. Lee JY, Kim H, Cha MY, Park HG, Kim YJ, Kim IY, et al. (2009) Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-kappaB signaling pathway. J Mol Med (Berl) 87: 169-180.
43. Castagliuolo I, Sardina M, Brun P, DeRos C, Mastroto C, Lovato L, et al. (2004) Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant. Infect Immun 72: 2827-2836. PMID: 15102793
44. Brun P, Scarpa M, Grillo A, Palu G, Mengoli C, Zecconi A, et al. (2008) Clostridium difficile TxAC314 and SLP-36kDa enhance the immune response toward a co-administered antigen. J Med Microbiol 57: 725-31 doi: 10.1099/jmm.0.47736-0 PMID: 18480329
45. Hussack G, Arbabi-Ghahroudi M, van Faassen H, Songer JG, Ng KK, MacKenzie R, et al. (2011) Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem 286: 8961-8976. doi: 10.1074/jbc.M110.198754 PMID: 21216961
46. Stabler RA, Dawson LF, Valiente E, Cairns MD, Martin MJ, Donahue EH, et al. (2012) Macro and micro diversity of Clostridium difficile isolates from diverse sources and geographical locations. PLOS ONE 7: e31559. doi: 10.1371/journal.pone.0031559 PMID: 22396735
47. Ward SJ, Douce G, Dougan G, Wren BW (1999) Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile. Infect Immun 67: 5124-5132. PMID: 10496886
48. Gerhard R, Frenzel E, Goy S, Olling A (2013) Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain. J Med Microbiol 62: 1414-1422. doi: 10.1099/jmm.0.057828-0 PMID: 23558138
49. Yeh CY, Lin CN, Chang CF, Lin CH, Lien HT, Chen JY, et al. (2008) C-terminal repeats of Clostridium difficile toxin A induce production of chemokine and adhesion molecules in endothelial cells and promote migration of leukocytes. Infect Immun 76: 1170-1178. PMID: 18160482
50. Frey SM, Wilkins TD (1992) Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A. Infect Immun 60: 2488-2493. PMID: 1375199
51. Gagliardi MC, Sallusto F, Marinaro M, Langenkamp A, Lanzavecchia A, De Magistris MT (2000). Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur J Immunol 30: 2394-2403. PMID: 10940931
52. Lavelle EC, Grant G, Pusztai A, Pfuller U, O'Hagan DT (2001) The identification of plant lectins with mucosal adjuvant activity. Immunology 102: 77-86. PMID: 11168640
53. Shen A (2012) Clostridium difficile toxins: mediators of inflammation. J Innate Immun 4: 149-158. doi: 10.1159/000332946 PMID: 22237401
54. Kim JM, Lee JY, Yoon YM, Oh YK, Youn J, Kim YJ (2006) NF-kappa B activation pathway is essential for the chemokine expression in intestinal epithelial cells stimulated with Clostridium difficile toxin A. Scand J Immunol 63: 453-460. PMID: 16764699
55. Flegel WA, Muller F, Daubener W, Fischer HG, Hadding U, Northoff H (1991) Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun 59: 3659-3666. PMID: 1910012